biotickrShandong Pharmaceutical Glass
The 600529-CG stock trades on Shanghai Stock Exchange
Company Description
Shandong Pharmaceutical Glass Co., Ltd. is currently one of the world's leading manufacturers of pharmaceutical glass packaging products and butyl rubber stoppers. The company was established in 1970 and has more than 50 years of production experience and history. The industry output, market share, economic benefits and other economic indicators are among the best, and it is also a listed company specializing in the manufacture of medicinal glass bottles and medicinal butyl rubber stoppers in the same industry, serving the pharmaceutical, food, and daily necessities industries. It has four branches and six subsidiaries under its jurisdiction. It is one of the few companies in the country that can provide a full set of " bottle + stopper + cap " pharmaceutical packaging services for pharmaceutical companies.
On January 24 , 2002, it was approved by the China Securities Regulatory Commission to issue 32 million A shares, and it was listed for trading on June 3 , 2002. It became an early listed company in China's pharmaceutical glass packaging industry, a national key high-tech enterprise, and a national torch plan. Project enterprise, drafting unit of national standards for pharmaceutical packaging products, executive director unit of China Pharmaceutical Packaging Association, top ten enterprises in national key industrial industries, top 30 enterprises in China's pharmaceutical industry and national advanced packaging enterprises, medicinal glass bottles and medicinal butyl rubber bottles The output of plugs is at the forefront of the country. The company is a joint-stock state-owned enterprise with a stock code of 600529. The financial report for the third quarter of 2020 shows that the company has a registered capital of 594.967747 million yuan, total assets of more than 5.43 billion yuan, and net assets attributable to shareholders of 4.106 billion yuan. The controlling shareholder of the company is Shandong Luzhong Investment Co., Ltd. (Actual shareholding is 21.72%), the company's annual sales revenue is nearly 3.4 billion yuan, and there are nearly 5,000 employees. Company website: www.pharmglass.com . Business license unified social credit code: 91370000168611868Q.
On January 24 , 2002, it was approved by the China Securities Regulatory Commission to issue 32 million A shares, and it was listed for trading on June 3 , 2002. It became an early listed company in China's pharmaceutical glass packaging industry, a national key high-tech enterprise, and a national torch plan. Project enterprise, drafting unit of national standards for pharmaceutical packaging products, executive director unit of China Pharmaceutical Packaging Association, top ten enterprises in national key industrial industries, top 30 enterprises in China's pharmaceutical industry and national advanced packaging enterprises, medicinal glass bottles and medicinal butyl rubber bottles The output of plugs is at the forefront of the country. The company is a joint-stock state-owned enterprise with a stock code of 600529. The financial report for the third quarter of 2020 shows that the company has a registered capital of 594.967747 million yuan, total assets of more than 5.43 billion yuan, and net assets attributable to shareholders of 4.106 billion yuan. The controlling shareholder of the company is Shandong Luzhong Investment Co., Ltd. (Actual shareholding is 21.72%), the company's annual sales revenue is nearly 3.4 billion yuan, and there are nearly 5,000 employees. Company website: www.pharmglass.com . Business license unified social credit code: 91370000168611868Q.
0 Comments on 600529-CG stock
Newest
Conversation